DexCom Inc. (DC4)
FSX
Closed
Oct 9, 2026
Day's Range
74.6052 wk Range
46.88Overview - DC4 - DexCom Inc.
Key Statistics
Valuation
Enterprise Value
24.67B
P/E (Trailing)
‪34.08‬
P/E (Forward)
‪21.52‬
PEG Ratio
‪0.82‬
Price / Sales (TTM)
‪5.77‬
Price / Book
‪12.44‬
EV / EBITDA
‪20.04‬
Profitability
Gross Margin
‪63.43%‬
Profit Margin
‪20.11%‬
Operating Margin
‪24.32%‬
Return on Assets
‪10.33%‬
Return on Equity
‪38.49%‬
Ownership
Shares Outstanding
377.40M
Float
375.99M
Held by Insiders
‪0.26%‬
Held by Institutions
‪106.39%‬
Price stats
Beta
‪1.41‬
50-Day Avg
‪73.85‬
200-Day Avg
‪62.53‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - DC4 - DexCom Inc.
Peers - DC4 - DexCom Inc.
Peer Comparison
Compared with companies in Medical Devices listed on FSX.
- DC4FSXDexCom Inc.28.67BMarket Cap+24.74%52-week change34.08P/E (Trailing)‪20.11%‬Profit Margin
- ABLFSXAbbott Laboratories149.23BMarket Cap-32.43%52-week change32.21P/E (Trailing)‪11.64%‬Profit Margin
- ABL0FSXAbbott Laboratories CDR142.74BMarket Cap-41.12%52-week change29.72P/E (Trailing)‪11.64%‬Profit Margin
- CFXFSXCapital One Financial Corp.104.87BMarket Cap-9.97%52-week change10.71P/E (Trailing)‪21.86%‬Profit Margin
- 2M6FSXMedtronic plc99.20BMarket Cap-3.24%52-week change21.91P/E (Trailing)‪13.93%‬Profit Margin
- SYKFSXStryker Corp.92.74BMarket Cap-29.94%52-week change28.48P/E (Trailing)‪14.43%‬Profit Margin
- ASGFSXAssicurazioni Generali S.p.A.62.81BMarket Cap+21.13%52-week change14.14P/E (Trailing)‪7.68%‬Profit Margin
Profile Summary - DC4 - DexCom Inc.
About
DexCom Inc. is a medical device company focused on continuous glucose monitoring systems for diabetes and metabolic health. Dexcom develops wearable biosensors, transmitters, receivers, and software that provide real-time glucose readings, trend data, and alerts to help users and clinicians monitor glucose levels…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
